Viveon Health Acquisition, a blank check company targeting the US orthopedic and spine industry, raised $175 million by offering 17.5 million units at $10. The company offered 0.5 million more units than anticipated. Each unit contains one share of common stock, one right to receive one-twentieth of a share common stock upon the consummation of an initial business combination, and one warrant to purchase one-half of a share of common stock, exercisable at $11.50.
The company is led by CEO Jagi Gill, who was previously VP of Business Development and General Manager of AcuVentures and the founder of orthopedics-focused companies Tenex Health and OrthoCor, and CFO Rom Papadopoulos, the founder and former Managing Partner of healthcare private equity firm Intuitus Capital. Viveon Health Acquisition plans to leverage its management team's experience and relationships in healthcare to target companies in the US orthopedic and spine industry.
Viveon Health Acquisition plans to list on the NYSE American under the symbol VHAQ.U. Chardan Capital Markets acted as a lead manager on the deal.
